![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 11, 2016 7:01:24 AM
Even though $OWCP has been played a lot, it holds better it's value than the rest of the MJ OTC stocks, probably due to some positive facts we have to not-forget.
1.- It had an offer that they declined by $TEVA. Even though (always in my opinion) 8 temporary patents don't mean anything (it cost like $200 to file a provisional patent in the US), the fact that a big pharma company tried to acquire those rights tell me $OWCP might be on the right track.
2.- No toxic debt. They recently got rid of an unwanted investor.
3.- A new investor came in, buying shares at $0.13, with options to buy more in the future at $0.25 and $0.40.
I've been here since $0.04, but I didn't check out (although I think I should have done that). I just invest long-term but this time I decided to include a little investment of my portfoliio in a nice OTC company, and for what I found searching, this one was the best around (or at least the one I liked more).
Good luck guys.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM